Alzheimer’s disease is a heartbreaking and incurable disease. It is a progressive mental deterioration that includes symptoms such as loss of memory and loss of cognitive functions.While there are drugs on the market that have shown some effectiveness in slowing the progression of the disease, Alzheimer’s disease is fatal.
In 2003 the medical director of the neonatal intensive care unit of Spring Hill Regional Hospital in Florida, Mary Newport, discovered that her husband was showing signs of Alzheimer’s disease. Despite being prescribed various drugs such as Aricept, Namenda, and Exelon, her husband’s conditioned continued to decline. “Many days, often for several days in a row, he was in a fog; couldn’t find a spoon or remember how to get water out of the refrigerator,” Mary said.
Mary Newport began to do research and found that many researchers found a lot of the symptoms of Alzheimer’s were due to starvation of certain brain cells inability to process glucose. Without this fuel, the neurons being to die. The same researchers wondered if giving the brain more energy from a different or alternative supply, like ketones, might help halt the disease. Consuming medium-chain triglycerides (MCT) will cause the body to produce ketones. MCT is a type of fat. When you take in MCT oil, the liver changes it into ketones.
Continuing with her research, Mary Newport learned that MCT oil from coconut or palm kernel oil showed great promise in the treatment of Alzheimer’s. In fact, the dose shown to show results was only 4 teaspoons, so she began giving it to her husband.
The results? Within only two days her husband was showing signs of improvement. Within 60 days he was alert, happy and joking, talkative, and his tremor was no longer noticeable. Within a year he was able to run and showed improvement in short-term memory and reading comprehension. He would recall recent conversations and events in detail. The atrophy in his brain had completely stopped, according to his most recent MRI.
Researchers are looking at MCT to be part of potential treatments for Parkinson’s disease, Huntington’s disease, MS, and Lou Gehrig’s disease (ALS), as well as Type 1 and Type 2 Diabetes.
